MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CYCN made $875,000 in revenue. -$976,000 in net income. Net profit margin of -111.54%.

Income Overview

Revenue
$875,000
Net Income
-$976,000
Net Profit Margin
-111.54%
EPS
-$0.3
Unit: Dollar
Revenue Breakdown
    • Purchase Agreement
    • Option Agreement

Unit: Dollar
Income Statement
2025-09-30
2025-03-31
2024-12-31
Total revenues
875,000 81,000 602,000
Research and development
348,000 36,000 68,333.333
General and administrative
1,533,000 1,502,000 1,367,000
Impairment loss
--0
Total cost and expenses
1,881,000 1,538,000 1,435,333.333
Loss from operations
-1,006,000 -1,457,000 -833,333.333
Interest income
30,000 -55,333.333
Gain from settlement of account payable
0 -0
Gain from insurance recovery
0 --
Total other income, net
30,000 -55,333.333
Net loss from continuing operations
---778,000
Gain from discontinued operations
--0
Net loss
-976,000 --778,000
Foreign currency translation adjustment loss
0 --
Comprehensive loss
-976,000 --
Earnings per share, diluted
-0.3 -0.56 -0.307
Net loss per share - basic
-0.3 -0.56 -0.307
Weighted average shares used in calculating net loss per share - basic
3,225,000 2,556,000 -2,666.667
Weighted average shares used in calculating net loss per share - diluted
3,225,000 2,556,000 -2,666.667
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$976,000 Interest income$30,000 Net loss-$976,000 Total other income,net$30,000 Option Agreement$75,000 Purchase Agreement$800,000 Loss from operations-$1,006,000 Total revenues$875,000 Total cost andexpenses$1,881,000 General andadministrative$1,533,000 Research and development$348,000

Cyclerion Therapeutics, Inc. (CYCN)

Cyclerion Therapeutics, Inc. (CYCN)